Physician profile
John E Peterson
NPI 1346249554
$325.62
in general payments reported to CMS, 2019-2025
8 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.25 · 2020: $16.52 · 2021: $18.86 · 2022: $24.56 · 2023: $21.95 · 2024: $21.87 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $209.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $149.93 | 2025 | Recell |
| Glaxosmithkline, LLC. | $59.61 | 2019-2020 | |
| Abbott Laboratories | $24.56 | 2022 | |
| Immunogen, INC. | $21.95 | 2023 | Elahere |
| Dexcom, INC. | $21.87 | 2024 | Dexcom G6 Transmitter |
| Mylan Specialty L.P. | $18.86 | 2021 | |
| Viiv Healthcare Company | $15.68 | 2025 | Apretude |
| Amarin Pharma, INC. | $13.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.